A postdoctoral position is available in a newer cancer research lab launched in April 2015 (Dai Horiuchi, Principal Investigator) at Northwestern University Feinberg School of Medicine in Chicago.
The major focus of the lab is to study the mechanisms of tumor progression in breast cancer and to identify novel targeted treatment strategies. To achieve these goals, we utilize a collection of human breast cancer cell lines, preclinical animal models, and high-throughput screening approaches along with state-of-the-art bioinformatics through collaboration with experts in the field. We are determined to bring basic laboratory findings to more advanced preclinical and clinical testing, and our research involves dynamic interactions with clinicians and pharmaceutical collaborators.
For more information about the Principal Investigator, please visit:
We are devoted to understanding the cellular events that influence the aggressiveness of breast tumors with our particular emphasis on the triple-negative breast cancer subtype, and are currently focused on the following areas:
(a) Mechanisms of tumor maintenance and progression medicated by proto-oncogenes (i.e., MYC transcription factor, PIM family of serine/threonine kinases, among others), their activators and effectors, and tumor microenvironment.
(b) Biology and therapeutic targetability of novel molecular factors that significantly influence patient clinical outcome.
We are seeking a highly motivated, recent Ph.D. who is passionate about the concept of “personalized medicine.” Prior in-depth training in (breast) cancer research involving rodent animal models (e.g., transgenic/syngeneic/PDX) as demonstrated by peer-reviewed publications is a must for this position.
For this round of recruitment, we are particularly interested in identifying an individual who would like to conduct postdoctoral research in the area of microenvironmental regulation of primary tumor progression. Additionally, a proven track record of or strong desire for employing bioinformatics approaches (basic expression analyses to more advanced machine learning methods) to take advantage of “big data” is a huge plus. The successful candidate will be provided with guidance tailored to his/her desired career paths (i.e., academic- or industry research, non-research career, etc).
As exemplified by the partnership between the Northwestern Cancer Center and Foundation Medicine, Inc., overall cancer research at Northwestern is on an exciting, rapid growth phase and provides enormous opportunities for us to positively impact the lives of cancer patients through innovative basic and translational research:
Please send an email with a brief introduction of your academic/research background and current career goals, curriculum vitae, and contact info for three references to Dai Horiuchi, Ph.D., Department of Pharmacology, R.H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine firstname.lastname@example.org. Successful candidates will be contacted via email.